ICD-10-PCS 2027 procedure code
XW023X7Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7
Short description: Introduce Tixagev/Cilgavim in Muscle, Perc, New Tech 7
Source: official FY2027 ICD-10-PCS release from CMS, effective October 1, 2026. Updated September 29, 2026. About our data
About XW023X7
XW023X7 is the ICD-10-PCS code for a introduction procedure . In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
With a different device, use XW023V7 (xanomeline and trospium chloride), XW023W7 (AGN1 bone void filler) and XW023Y7 (other new technology monoclonal antibody).
It was added in FY2023, effective October 1, 2022.
What each character means
- 1. Section
- XNew Technology
- 2. Body System
- WAnatomical Regions
- 3. Operation
- 0Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
- 4.
- 2
- 5.
- 3
- 6.
- X
- 7.
- 7
Other versions of this procedure
Different device / substance / technology
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2023 (effective 10/1/2022): Added
- FY2027 (effective 10/1/2026): Deleted
Common questions about XW023X7
Is XW023X7 a valid ICD-10-PCS code for 2027?
- No. It was deleted in FY2027.